急性ST段抬高型心肌梗死溶栓治疗的疗效与安全性分析

Analysis of efficacy and safety of thrombolytic therapy on acute ST-segment elevation myocardial infarction

目的:分析溶栓治疗急性ST段抬高型心肌梗死的疗效与安全性。方法:2019年1-12月收治急性ST段抬高型心肌梗死患者100例,使用溶栓治疗,分析治疗效果和安全性。结果:溶栓成功92例(92.00%);出现咯血1例,消化道出血2例,心源性休克1例,不良反应发生率为4.00%。年龄<70岁的患者和≥70岁患者的溶栓成功率和不良反应发生率比较,差异无统计学意义(P>0.05)。结论:急性ST段抬高型心肌梗死患者的最佳方式是使用静脉溶栓治疗后,再使用灌注治疗,能够让溶栓治疗疗效增加,同时不良反应降低,安全性升高。

Objective:To analyze the efficacy and safety of thrombolytic therapy for acute ST-segment elevation myocardial infarction.Methods:From January to December 2019,100 cases of patients with acute ST-segment elevation myocardial infarction were treated with thrombolytic therapy,then the therapeutic effect and safety were analyzed.Results:92 cases of thrombolysis were successful(92.00%).There was 1 case of hemoptysis,2 cases of gastrointestinal bleeding,and 1 case of cardiogenic shock,the incidence of adverse reactions was 4.00%.The thrombolysis success rate and the incidence of adverse reactions between patients who were younger than 70 years old and patients who were older than 70 years old were compared,the differences were not statistically significant(P>0.05).Conclusion:The best way for patients with acute ST segment elevation myocardial infarction is to use intravenous thrombolytic therapy firstly and then use reperfusion therapy,which can increase the curative effect of thrombolytic therapy,and the adverse reeaction is low and the safety is high.